<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Risteys – K11_REIMB_202 – detailed case counts by code</title>
		<style type="text/css">
body {
	font-family: sans-serif;
}
.bar-plot-full {
	width: 8rem;
	border-radius: 0.1rem;
	background-color: #f2f2f2;
}
.bar-plot-full div {
	background-color: #c7c7c7;
	height: 1rem;
	border-radius: 0.1rem;
}
		</style>
	</head>
	<body>

		<table>
			<tr>
				<th>Source</th>
				<th>Code</th>
				<th>Name</th>
				<th>Case count</th>
				<th>Share of cases (%)</th>
			</tr>

			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD8(NA)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>2472</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 13.068992862807297%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(NA)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>1923</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 10.166534496431403%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M05)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Seropositive rheumatoid arthritis</td>
					<td>1817</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.606132698916205%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M058)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other seropositive rheumatoid arthritis</td>
					<td>1734</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.167327517842981%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M139)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Arthritis, unspecified</td>
					<td>1700</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.987575997885276%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(L405)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Arthropathic psoriasis (M07.0-M07.3*, M09.0*)</td>
					<td>1455</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 7.6923076923076925%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M06)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other rheumatoid arthritis</td>
					<td>1364</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 7.211208035950303%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M45)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Ankylosing spondylitis</td>
					<td>1000</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.286809410520751%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M35)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other systemic involvement of connective tissue</td>
					<td>644</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.4047052603753634%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M060)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Seronegative rheumatoid arthritis</td>
					<td>537</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.8390166534496433%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M08)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Juvenile arthritis</td>
					<td>386</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.0407084324610096%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M461)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Sacroiliitis, not elsewhere classified</td>
					<td>365</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.929685434840074%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(K743)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Primary biliary cirrhosis</td>
					<td>304</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.607190060798308%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(K830)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Cholangitis</td>
					<td>277</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.4644462067142479%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(NA)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>256</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.3534232090933123%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M469)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Inflammatory spondylopathy, unspecified</td>
					<td>255</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.3481363996827915%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M02)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Reactive arthropathies</td>
					<td>213</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.12609040444092%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M059)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Seropositive rheumatoid arthritis, unspecified</td>
					<td>185</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9780597409463389%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(714)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Rheumatoid arthritis and other inflammatory polyarthropathies</td>
					<td>182</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9621993127147767%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(K732)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Chronic active hepatitis, not elsewhere classified</td>
					<td>173</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.91461802802009%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M359)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Systemic involvement of connective tissue, unspecified</td>
					<td>157</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8300290774517579%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7140A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis</td>
					<td>156</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8247422680412372%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M353)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Polymyalgia rheumatica</td>
					<td>153</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.808881839809675%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M32)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Systemic lupus erythematosus</td>
					<td>146</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7718741739360296%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M350)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Sicca syndrome [Sjögren]</td>
					<td>145</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7665873645255088%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M31)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other necrotizing vasculopathies</td>
					<td>136</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7190060798308221%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M084)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Pauciarticular juvenile arthritis</td>
					<td>123</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6502775574940524%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M069)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Rheumatoid arthritis, unspecified</td>
					<td>116</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6132698916204071%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(H201)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Chronic iridocyclitis</td>
					<td>103</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.5445413692836373%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M029)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Reactive arthropathy, unspecified</td>
					<td>96</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.507533703409992%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(J841)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other interstitial pulmonary diseases with fibrosis</td>
					<td>91</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.48109965635738833%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M329)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Systemic lupus erythematosus, unspecified</td>
					<td>88</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.4652392281258261%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M083)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Juvenile polyarthritis (seronegative)</td>
					<td>87</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.45995241871530534%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M313)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Wegener's granulomatosis</td>
					<td>87</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.45995241871530534%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(J84)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other interstitial pulmonary diseases</td>
					<td>86</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.4546656093047846%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M34)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Systemic sclerosis</td>
					<td>85</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.44937879989426377%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M341)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, CR(E)ST syndrome</td>
					<td>73</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3859370869680148%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7200A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Ankylosing spondylitis</td>
					<td>70</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3700766587364525%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M315)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Giant cell arteritis with polymyalgia rheumatica</td>
					<td>69</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3647898493259318%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7140B)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis</td>
					<td>62</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.32778218345228655%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M351)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other overlap syndromes</td>
					<td>55</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2907745175786413%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(6960A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Psoriatic arthropathy</td>
					<td>48</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.253766851704996%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7140)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>47</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.24848004229447526%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M33)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Dermatopolymyositis</td>
					<td>45</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.23790642347343377%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M064)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Inflammatory polyarthropathy</td>
					<td>38</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2008987575997885%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(N03)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Chronic nephritic syndrome</td>
					<td>37</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.19561194818926778%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(K519)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Ulcerative colitis, unspecified</td>
					<td>33</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1744647105471848%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(720)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Ankylosing spondylitis and other inflammatory spondylopathies</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.16917790113666403%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M068)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other specified rheumatoid arthritis</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.16389109172614327%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M30)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Polyarteritis nodosa and related conditions</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.16389109172614327%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M349)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Systemic sclerosis, unspecified</td>
					<td>29</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.15331747290510178%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M089)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Juvenile arthritis, unspecified</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13745704467353953%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(K509)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Crohn's disease, unspecified</td>
					<td>25</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13217023526301877%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7143D)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis</td>
					<td>25</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13217023526301877%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M332)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Polymyositis</td>
					<td>24</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.126883425852498%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M317)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Microscopic polyangiitis</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.12159661644197726%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7100A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Systemic lupus erythematosus</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.12159661644197726%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M028)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other reactive arthropathies</td>
					<td>22</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11630980703145652%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(Q442)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>21</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11102299762093576%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(711)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Arthropathy associated with infections</td>
					<td>21</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11102299762093576%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M328)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other forms of systemic lupus erythematosus</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10044937879989425%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M021)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Postdysenteric arthropathy</td>
					<td>18</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09516256938937351%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M07)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Psoriatic and enteropathic arthropathies</td>
					<td>18</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09516256938937351%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M941)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Relapsing polychondritis</td>
					<td>17</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08987575997885276%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7200)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>17</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08987575997885276%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M081)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Juvenile ankylosing spondylitis</td>
					<td>16</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08458895056833202%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M339)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Dermatopolymyositis, unspecified</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07930214115781126%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7143)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07930214115781126%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7143C)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07930214115781126%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M061)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Adult-onset Still's disease</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07401533174729051%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M319)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Necrotizing vasculopathy, unspecified</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07401533174729051%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M358)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other specified systemic involvement of connective tissue</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07401533174729051%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(N04)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Nephrotic syndrome</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07401533174729051%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(696)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Psoriasis and similar disorders</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07401533174729051%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M080)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Juvenile rheumatoid arthritis</td>
					<td>13</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06872852233676977%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M301)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Polyarteritis with lung involvement [Churg-Strauss]</td>
					<td>13</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06872852233676977%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7168A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other specified arthropathy</td>
					<td>13</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06872852233676977%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M316)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other giant cell arteritis</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.063441712926249%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(6960)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.063441712926249%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(710)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Diffuse diseases of connective tissue</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.063441712926249%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M023)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Reiter's disease</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05815490351572826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7109X)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Unspecified diffuse connective tissue disease</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05815490351572826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7148X)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other specified inflammatory polyarthropathies</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05815490351572826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7250A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Polymyalgia rheumatica</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05815490351572826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(M05)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05815490351572826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(J849)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Interstitial pulmonary disease, unspecified</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05286809410520751%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M318)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other specified necrotizing vasculopathies</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05286809410520751%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M331)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other dermatomyositis</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05286809410520751%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M321)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Systemic lupus erythematosus with organ or system involvement</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.047581284694686754%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M450)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.047581284694686754%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(714)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04229447528416601%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(H302)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Posterior cyclitis</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04229447528416601%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7165A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Unspecified polyarthropathy or polyarthritis</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04229447528416601%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(M06)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04229447528416601%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M314)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Aortic arch syndrome [Takayasu]</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.037007665873645255%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M352)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Behçet's disease</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.037007665873645255%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(A046)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Enteritis due to Yersinia enterocolitica</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0317208564631245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(H30)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Chorioretinal inflammation</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0317208564631245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M066)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0317208564631245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(N042)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Nephrotic syndrome, diffuse membranous glomerulonephritis</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0317208564631245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(N049)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Nephrotic syndrome, unspecified</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0317208564631245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7100)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0317208564631245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7202A)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Sacroiliitis, not elsewhere classified</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0317208564631245%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(J848)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other specified interstitial pulmonary diseases</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M020)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Arthropathy following intestinal bypass</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M348)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other forms of systemic sclerosis</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(M451)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Name not found</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(N032)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Chronic glomerulonephritis diffuse membranous glomerulonephritis</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(N038)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Chronic glomerulonephritis Other specified glomerulonephritis</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD10(N039)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Chronic glomerulonephritis UNS</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(446)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Polyarteritis nodosa and allied conditions</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7108X)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other specified diffuse diseases of connective tissue</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(716)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Other and unspecified arthropathies</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(202)_ICD9(7209X)</td>
					<td>Connective tissue diseases, rheumatoid arthritis and comparable disease, Unspecified inflammatory spondylopathy</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.026434047052603753%"></div>
						</div>
						
					</td>
				</tr>
			

		</table>

	</body>
</html>
